THINK Surgical announced the completion of first cases using the TMINI Miniature Robotic System combined with Stryker’s Triathlon Knee System.
Multiple surgeons and hospitals have performed cases nationwide with this additional compatible implant offering. THINK Surgical will continue to expand commercialization this year.
THINK Surgical recently received FDA 510(k) clearance for TMINI System’s compatibility with the Stryker Triathlon Knee. This further expands implant options for surgeons using the TMINI System, which now includes nine different compatible implant options.
“The addition of the Triathlon Knee System to our platform further demonstrates THINK Surgical’s commitment to open platform robotics and empowering surgeon choice,” said Stuart Simpson, CEO and President of THINK Surgical. “We believe that implant agnostic technology enables surgeons to deliver a more personalized solution for each patient, potentially leading to better clinical outcomes.”
THINK Surgical announced the completion of first cases using the TMINI Miniature Robotic System combined with Stryker's Triathlon Knee System.
Multiple surgeons and hospitals have performed cases nationwide with this additional compatible implant offering. THINK Surgical will continue to expand commercialization this year.
THINK Surgical...
THINK Surgical announced the completion of first cases using the TMINI Miniature Robotic System combined with Stryker’s Triathlon Knee System.
Multiple surgeons and hospitals have performed cases nationwide with this additional compatible implant offering. THINK Surgical will continue to expand commercialization this year.
THINK Surgical recently received FDA 510(k) clearance for TMINI System’s compatibility with the Stryker Triathlon Knee. This further expands implant options for surgeons using the TMINI System, which now includes nine different compatible implant options.
“The addition of the Triathlon Knee System to our platform further demonstrates THINK Surgical’s commitment to open platform robotics and empowering surgeon choice,” said Stuart Simpson, CEO and President of THINK Surgical. “We believe that implant agnostic technology enables surgeons to deliver a more personalized solution for each patient, potentially leading to better clinical outcomes.”
Copy to clipboard 
